Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-30

Clinical Trial Update: Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of a combined EGCG and tocotrienol regimen in 18 patients with splicing-mutation-mediated cystic fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EGCG (epigallocatechin gallate)
  • Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Cystic Fibrosis | NA | Status: COMPLETED